Astellas Pharma Prices New Unsecured Bonds

Astellas Pharma (JP:4503) has released an update.

Astellas Pharma Inc. has announced the successful pricing of its 5th and 6th series JPY denominated unsecured bonds, aimed at repaying and redeeming short-term fundings. The bonds total JPY 100 billion, with the 5th series bond at JPY 80 billion with a 0.870% interest rate and a 5-year maturity, and the 6th series bond at JPY 20 billion with a 1.038% interest rate and a 7-year maturity. Both series are set to be publicly offered with no collateral guarantees but include a negative pledge clause, with Mizuho Securities and others as lead managers.

For further insights into JP:4503 stock, check out TipRanks’ Stock Analysis page.